Abstract:This editorial refers to ‘A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling’ by D.J. Kennedy et al. , pp. 604–613, this issue. Insulin resistance, a decreased metabolic responsiveness of peripheral organs and tissues to insulin, is considered the central mechanism of metabolic syndrome, a cluster of cardiovascular risk factors, including abdominal obesity, hypertension, a pro-atherogenic lipid profile, a pro-thrombotic, pro-inflammatory state, and dysglycemia. Studies in recent years have revealed the causal role of chronic low-grade inflammation in development of obesity-associated insulin resistance in animal models.1 Since chronic inflammation also plays a pivotal role in atherosclerotic cardiovascular disease,2 it is therefore considered to be the fundamental mechanistic link between insulin resistance and increased cardiovascular prevalence in obesity. Compelling evidence from numerous studies in animal models demonstrates that monocytes are recruited to adipose tissue during obesity and become macrophages through interaction with dysfunctional adipocytes.3 Moreover, resident adipose tissue macrophages may switch their phenotype from the anti-inflammatory ‘alternative’ (M2) to pro-inflammatory ‘classical’ (M1) macrophages during expansion of adipose tissue in obesity.4 Accumulation of macrophages and phenotypic switch from M2 to M1 macrophages has been suggested to play a determinant role in insulin resistance in obesity at least in mouse models.3 Increased adipose tissue inflammation and macrophage infiltration have been confirmed in human obesity.5 However, subset macrophage accumulation in human adipose tissue in obesity requires further characterization. There is much interest in the question of what are the micro-environmental changes in adipose tissue in obesity that initiate and regulate adipose tissue inflammation. Adipocytes …

Emerging Functions of Adipokines in Linking the Development of Obesity and Cardiovascular Diseases

Adipokines As Novel Biomarkers of Cardio-Metabolic Disorders

New Insights into Different Adipokines in Linking the Pathophysiology of Obesity and Psoriasis

Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases

Multifaced Roles of Adipokines in Endothelial Cell Function

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

Adipokines in Inflammation, Insulin Resistance and Cardiovascular Disease.

Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk

An Overview of the Role of Adipokines in Cardiometabolic Diseases

Adiponectin and Metabolic Cardiovascular Diseases: Therapeutic Opportunities and Challenges.

Research progress of adipokines related with obesity

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation

Mechanism and Clinical Evidence of Lipocalin‐2 and Adipocyte Fatty Acid‐binding Protein Linking Obesity and Atherosclerosis

Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease

New Insights into Adipose Tissue Macrophages in Obesity and Insulin Resistance

Mechanisms of Inflammatory Responses in Obese Adipose Tissue

Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity.

Adiponectin and interleukin-6 in inflammation-associated disease.

Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases

Organokines and Exosomes: Integrators of Adipose Tissue Macrophage Polarization and Recruitment in Obesity

CD36: the Common Soil for Inflammation in Obesity and Atherosclerosis?